| Report Title | Price | Action |
|---|---|---|
| Anal Fissure (Gastrointestinal) - Drugs in Development, 2021
Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 Summary Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021
Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 Summary Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs i...
Published: Apr-2021 | No. of Pages: 170
|
$ 3000 | |
| Claudin 18 (CLDN18) - Drugs in Development, 2021
Claudin 18 (CLDN18) - Drugs in Development, 2021 Summary Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Drugs in Development, 2021
Potassium Voltage Gated Channel Subfamily A Member 3 (Voltage Gated Potassium Channel Subunit Kv1.3 or KCNA3) - Drugs in Development, 2021 Summary P...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Ascites (Gastrointestinal) - Drugs in Development, 2021
Ascites (Gastrointestinal) - Drugs in Development, 2021 Summary Ascites (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021 Summary 5-Hydroxytryptamine Receptor 2A (5 H...
Published: Apr-2021 | No. of Pages: 170
|
$ 3000 | |
| Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Summary Coagulation Factor XII (Hageman Factor or...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 (CACNA2D1) - Drugs in Development, 2021
Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 (CACNA2D1) - Drugs in Development, 2021 Summary Voltage Dependent Calcium Channel Subunit Al...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Enteritis (Gastrointestinal) - Drugs in Development, 2021
Enteritis (Gastrointestinal) - Drugs in Development, 2021 Summary Enteritis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Receptor flk 1 or VEGFR2 or CD309 or KDR or EC 2.7.10.1) - Drugs in Development, 2021
Vascular Endothelial Growth Factor Receptor 2 (Fetal Liver Kinase 1 or Kinase Insert Domain Receptor or Protein Tyrosine Kinase Receptor flk 1 or VEGF...
Published: Apr-2021 | No. of Pages: 180
|
$ 3500 | |
| Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021
Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Summary Co...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protein p120 or TRPA1) - Drugs in Development, 2021
Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protei...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021
Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Drugs in Development, 2021 Summary Aicardi-Goutieres Syndrome (AGS) (Genetic Disorders) - Dru...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021
Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 Summary Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 190
|
$ 3500 | |
| CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021
CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3C...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Transient Receptor Potential Cation Channel Subfamily M Member 8 (Long Transient Receptor Potential Channel 6 or Transient Receptor Potential p8 or TRPM8) - Drugs in Development, 2021
Transient Receptor Potential Cation Channel Subfamily M Member 8 (Long Transient Receptor Potential Channel 6 or Transient Receptor Potential p8 or TR...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021
Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Virion Infectivity Factor (SOR Protein or vif) - Drugs in Development, 2021
Virion Infectivity Factor (SOR Protein or vif) - Drugs in Development, 2021 Summary Virion Infectivity Factor (SOR Protein or vif) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021
D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 Summary D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs...
Published: Apr-2021 | No. of Pages: 190
|
$ 3500 | |
| DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021
DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in Development, 2021 Summary DNA Directed RNA Polymerase (POLR2 or EC 2.7.7.6) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 |